Our current practice is to consider a ~20% bolus insulin decrease and a ~10% basal insulin decrease before GLP-1RA initiation, although prior A1c, risk of hypoglycemia, potential risk of ketosis due to reduced insulin doses, as well as other patient-specific factors should guide the final insulin dose changes
Lila 2.0 Supersonic Rich Ortiz #HealthPolicy #Obesity #GovernmentRegulations #GLP-1 #SocialPrescriptions To view or add a comment, sign in How standardized are prescribing patterns across Canadian hospitals
The new neurometabolic cascade of concussion
Off-label prescribing for minor weight loss

Hypothyriodism, Hyperthyriodism, Glycemic Management for Children with Diabetes Glucose Monitoring Adrenal Insufficiency Turner Syndrome Late Adolescence Klinefelter Syndrome Children with Short Stature and Growth Failure: Heightism Type 1 Diabetes in Children Growth Hormone Treatment for GHD Insulin-like Growth Factor-I Growth Hormone Deficiency SGA Children with Short Stature Receiving GH Treatment Hypothalamic Obesity Adolescent Gynecomastia Hematospermia in Adolescents Gain-of-Function CDKN1C Mutations Craniopharyngioma Succinate-Dehydrogenase Deficient Paragangliomas/Pheochromocytomas Adrenal Steroidogenesis: Impact on Gonadal Function Focal Congenital Hyperinsulinism (CHI) Longevity Hormone Klotho Pediatric Congenital Hypothyroid Lysosomal Storage Diseases Juvenile NCL (CLN3 Disease) GM1 and GM2 Gangliosidoses Types A and B Niemann-Pick Disease CLN2 Disease (Classic Late Infantile Neuronal Ceroid Lipofuscinosis) Krabbe Disease Fucosidosis Nuclear Factor Kappa B (NF-B) in Growth Plate Chondrogenesis Persistent Mllerian Duct Syndrome LHX4 Gene Alterations Stunted Growth 45,X/46,XY Gonadal Dysgenesis Thyroid Hemiagenesis Nutrimetabolomics and Adipocitokines Chromosomal Microarray Analysis (CMA) Chromosomal microarray, Copy Number Variant (CNV), Prenatal, Amniocentesis, Comparative genomic hybridization, SNP array, Diagnosis, Clinical Abreviations: aCGH array-based comparative genomic hybridization, ASD autism spectrum disorder, BAC bacterial artificial chromosome, CHD congenital heart disease, CMA chromosomal microarray analysis, CNV copy number variant, CVS chorionic villus sampling, DD developmental delay, DNA deoxyribonucleic acid, FISH fluorescent in situ hybridization, GABA - gammaaminobutyric acid, ID intellectual disability, LOH loss of heterozygosity, NGS next generation sequencing, NIPT noninvasive prenatal testing, NOS not otherwise specified, PGD - preimplantation genetic diagnosis, SNP single nucleotide polymorphism, VUS variant of unclear clinical significance Central precocious puberty, Traumatic brain injury, Pathophysiology Nephrolithiasis, Nephrocalcinosis, Hypercalciuria, Hyperoxaluria, Hypouricemia, Cystinuria, Genetics

You may not assign these Terms without our written consent